This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Han-Kyeng Kim: Innovator in Pharmaceutical Chemistry
Introduction
Han-Kyeng Kim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work is characterized by a focus on efficiency and high yield in chemical reactions.
Latest Patents
Han-Kyeng Kim holds a patent for a process titled "Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one." This invention describes a method for preparing pure 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a pharmaceutically acceptable salt thereof. The process is notable for its simplicity and high yield, utilizing a reaction between 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one and a 2-methylimidazole derivative in an organic solvent or a mixture of an organic solvent and water, facilitated by a halosilane compound.
Career Highlights
Throughout his career, Han-Kyeng Kim has been associated with Hanmi Pharm. Co., Ltd., a leading pharmaceutical company in South Korea. His work at Hanmi Pharm has allowed him to focus on innovative drug development and contribute to advancements in the pharmaceutical industry.
Collaborations
Han-Kyeng Kim has collaborated with notable colleagues, including Kwang-Ok Lee and Hee-Seock Kim. These collaborations have further enhanced his research and development efforts in the field of pharmaceuticals.
Conclusion
Han-Kyeng Kim is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His innovative approach and successful patent demonstrate his commitment to improving pharmaceutical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
